Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03637998 · ClinicalTrials.gov registry record · NA
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
A NA study, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03637998: Completed NA study, sponsored by University of Connecticut.
NCT03637998 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03637998, a NA study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This pilot project will provide an understanding of the contextual variables responsible for chronic low back pain. These variables include, genetic variation, pain sensitivity, reactivity, pain catastrophizing, perceived stress and kinesiphobia. The purpose is to understand the initial efficacy of self-management (SM) strategies on each of these contextual variables, in an effort to inform a personalized approach to managing chronic low back pain and its effect on improved health outcomes.
Primary Outcome
Fitbit for activity tracker
Interventions
- BEHAVIORAL Problem-solving Pain to Enhance Living Well (PROPEL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-09-21 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT03637998 record still lists
NCT03637998 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Problem-solving Pain to Enhance Living Well (PROPEL) is the first listed.
NCT03637998 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03637998 about?
NCT03637998 is a clinical study titled "Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain". This pilot project will provide an understanding of the contextual variables responsible for chronic low back pain. These variables include, genetic variation, pain sensitivity, reactivity, pain catastrophizing, perceived stress and kinesiphobia. The purpose is to understand the initial efficacy of ...
What is the current status of trial NCT03637998?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-09-21. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03637998?
The interventions under investigation include: Problem-solving Pain to Enhance Living Well (PROPEL) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03637998?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03637998's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI